{
  "ticker": "MYGN",
  "success": true,
  "price": {
    "current": 5.54,
    "currency": "USD",
    "day_high": 5.75,
    "day_low": 5.525,
    "52_week_high": 15.47,
    "52_week_low": 3.76
  },
  "market_cap": {
    "value": 516404000.0,
    "currency": "USD"
  },
  "shares_outstanding": 93213722.0,
  "volume": {
    "last": 644879,
    "average_30d": 886541
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": 81.59057,
    "price_to_book": 1.3836163
  },
  "company_info": {
    "name": "Myriad Genetics, Inc.",
    "sector": "Healthcare",
    "industry": "Diagnostics & Research"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 728100000.0,
    "total_liabilities": 355300000.0,
    "stockholders_equity": 372800000.0,
    "cash": 145400000.0,
    "marketable_securities": null,
    "total_liquidity": 145400000.0,
    "total_debt": 212300000.0,
    "long_term_debt": 119500000.0,
    "current_debt": 7900000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 21100000.0,
    "free_cash_flow": 14900000.0,
    "investing_cash_flow": -6200000.0,
    "financing_cash_flow": 56200000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 167100000.0,
    "research_and_development": 28200000.0,
    "interest_expense": 3800000.0,
    "net_income": -27400000.0,
    "revenue": 205700000.0,
    "gross_profit": 143800000.0,
    "ebitda": -9800000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:49:38.093597",
    "url": "https://finance.yahoo.com/quote/MYGN",
    "data_hash": "420b65c7c461ef41"
  }
}